NCT03466918View on ClinicalTrials.gov

China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 23, 2018

Primary Completion Date

July 3, 2019

Study Completion Date

June 19, 2024

Conditions
Aortic StenosisSymptomatic Aortic StenosisAortic Regurgitation
Interventions
DEVICE

SAPIEN 3 THV with the Commander delivery system

Edwards SAPIEN 3 Transcatheter Heart Valve is implanted using the Commander delivery system

Trial Locations (4)

Unknown

Fuwai Hospital, CAMS&PUMC, Beijing

WestChina Hospital, Sichuan University, Chengdu

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Zhongshan Hospital Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY